GLA
AMGN icon

Good Life Advisors’s Amgen AMGN Stock Holding History

Good Life Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$378K Sell
1,353
-427
-24% -$121K 0.02% 352
2025
Q1 		$555K Buy
1,780
+154
+9% +$45.5K 0.04% 278
2024
Q4 		$424K Sell
1,626
-25
-2% -$7.42K 0.03% 325
2024
Q3 		$532K Buy
1,651
+243
+17% +$79.5K 0.03% 329
2024
Q2 		$440K Buy
1,408
+169
+14% +$49.6K 0.04% 284
2024
Q1 		$352K Sell
1,239
-190
-13% -$55.6K 0.03% 310
2023
Q4 		$412K Sell
1,429
-126
-8% -$34.3K 0.04% 267
2023
Q3 		$418K Sell
1,555
-100
-6% -$25K 0.05% 238
2023
Q2 		$368K Buy
1,655
+61
+4% +$14.2K 0.04% 276
2023
Q1 		$386K Sell
1,594
-2
-0.1% -$491 0.05% 246
2022
Q4 		$419K Buy
1,596
+35
+2% +$9.38K 0.06% 219
2022
Q3 		$352K Buy
1,561
+251
+19% +$60.8K 0.05% 232
2022
Q2 		$319K Buy
1,310
+22
+2% +$5.39K 0.04% 253
2022
Q1 		$311K Sell
1,288
-6
-0.5% -$1.38K 0.04% 279
2021
Q4 		$291K Sell
1,294
-30
-2% -$6.33K 0.04% 291
2021
Q3 		$282K Buy
1,324
+303
+30% +$69.7K 0.04% 280
2021
Q2 		$249K Buy
+1,021
New +$251K 0.05% 258
2020
Q4 		– Sell
-832
Closed -$214K – 276
2020
Q3 		$214K Sell
832
-110
-12% -$27.3K 0.06% 216
2020
Q2 		$222K Buy
+942
New +$215K 0.07% 213
2020
Q1 		– Sell
-940
Closed -$227K – 223
2019
Q4 		$227K Buy
+940
New +$207K 0.06% 228
2019
Q1 		– Sell
-1,315
Closed -$256K – 247
2018
Q4 		$256K Sell
1,315
-183
-12% -$35.7K 0.08% 181
2018
Q3 		$312K Sell
1,498
-793
-35% -$156K 0.09% 167
2018
Q2 		$422K Sell
2,291
-478
-17% -$84.6K 0.13% 128
2018
Q1 		$456K Buy
2,769
+13
+0.5% +$2.39K 0.15% 116
2017
Q4 		$497K Buy
2,756
+29
+1% +$5.13K 0.15% 106
2017
Q3 		$505K Sell
2,727
-258
-9% -$45.7K 0.19% 89
2017
Q2 		$515K Buy
2,985
+352
+13% +$57.3K 0.23% 77
2017
Q1 		$429K Buy
+2,633
New +$438K 0.21% 89

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Good Life Advisors's AMGN Position: Q2 2025 in Review

Good Life Advisors reduced its Amgen (AMGN) stake by 24% in Q2 2025, selling an estimated $121K and leaving 1,353 shares worth $378K. The position accounts for 0.02% of the portfolio, ranked #352.

Good Life Advisors first reported a position in AMGN in Q1 2017 and has held it in 28 quarters since. The position peaked at $555K in Q1 2025. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Good Life Advisors held 1,353 shares of Amgen worth $378K as of Q2 2025.
  • Good Life Advisors sold 427 Amgen shares in Q2 2025, an estimated $121K.
  • Amgen made up 0.02% of Good Life Advisors's portfolio in Q2 2025, its #352 holding.
  • Good Life Advisors first reported a position in Amgen in Q1 2017 and has held it in 28 quarters since.
  • Good Life Advisors's Amgen position peaked at $555K in Q1 2025.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.